In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 7, p. 1425-1434
|
In: The Journal of Clinical Endocrinology & Metabolism, 2018, vol. 103, no. 8, p. 2988-2997
|
In: American Journal of Respiratory Cell and Molecular Biology, 2020, vol. 63, no. 5, p. 571–590
PARP1, the major isoform of a family of ADP-ribosylating enzymes, has been implicated in the regulation of various biological processes including DNA repair, gene transcription, and cell death. The concept that PARP1 becomes activated in acute lung injury (ALI) and that pharmacological inhibition or genetic deletion of this enzyme can provide therapeutic benefits emerged over 20 years ago....
|
In: Frontiers in Physiology, 2019, vol. 10, p. -
Hypoxia plays a crucial role in the pathogenesis of cardiovascular diseases. Mitochondrial enzyme arginase type II (Arg-II) is reported to lead to endothelial dysfunction and enhance the expression of endothelial inflammatory adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). In this study, we investigate the role of Arg-II in...
|
In: Basic Research in Cardiology, 2014, vol. 109, no. 1, p. 1-15
|
In: Internal and Emergency Medicine, 2014, vol. 9, no. 4, p. 411-417
|
In: Seminars in Immunopathology, 2014, vol. 36, no. 1, p. 73-91
|
In: Cell and Tissue Research, 2014, vol. 355, no. 3, p. 701-715
|
In: Pflügers Archiv - European Journal of Physiology, 2010, vol. 459, no. 6, p. 1005-1013
|
In: Seminars in Immunopathology, 2009, vol. 31, no. 1, p. 63-77
|